GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » ROA %

Panacea Biotec (BOM:531349) ROA % : -0.69% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Panacea Biotec's annualized Net Income for the quarter that ended in Dec. 2023 was ₹-88 Mil. Panacea Biotec's average Total Assets over the quarter that ended in Dec. 2023 was ₹12,722 Mil. Therefore, Panacea Biotec's annualized ROA % for the quarter that ended in Dec. 2023 was -0.69%.

The historical rank and industry rank for Panacea Biotec's ROA % or its related term are showing as below:

BOM:531349' s ROA % Range Over the Past 10 Years
Min: -14.05   Med: -3.73   Max: 73.44
Current: -0.9

During the past 13 years, Panacea Biotec's highest ROA % was 73.44%. The lowest was -14.05%. And the median was -3.73%.

BOM:531349's ROA % is ranked better than
82.53% of 1551 companies
in the Biotechnology industry
Industry Median: -34.84 vs BOM:531349: -0.90

Panacea Biotec ROA % Historical Data

The historical data trend for Panacea Biotec's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec ROA % Chart

Panacea Biotec Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.53 -14.05 -11.50 73.44 -2.19

Panacea Biotec Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.74 -3.83 3.46 -2.61 -0.69

Competitive Comparison of Panacea Biotec's ROA %

For the Biotechnology subindustry, Panacea Biotec's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacea Biotec's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's ROA % distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's ROA % falls into.



Panacea Biotec ROA % Calculation

Panacea Biotec's annualized ROA % for the fiscal year that ended in Mar. 2023 is calculated as:

ROA %=Net Income (A: Mar. 2023 )/( (Total Assets (A: Mar. 2022 )+Total Assets (A: Mar. 2023 ))/ count )
=-332.37/( (17588.69+12711.66)/ 2 )
=-332.37/15150.175
=-2.19 %

Panacea Biotec's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-88/( (12721.6+0)/ 1 )
=-88/12721.6
=-0.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Panacea Biotec  (BOM:531349) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-88/12721.6
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-88 / 6020)*(6020 / 12721.6)
=Net Margin %*Asset Turnover
=-1.46 %*0.4732
=-0.69 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Panacea Biotec ROA % Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Biotec (BOM:531349) Business Description

Traded in Other Exchanges
Address
Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (BOM:531349) Headlines

No Headlines